Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Curr Hematol Malig Rep. 2018 Dec;13(6):494–506. doi: 10.1007/s11899-018-0480-8

Figure 1.

Figure 1.

Diagram showing the different published approaches to target T cell leukemia and lymphoma.

All approaches in the figure and references:

Monoclonal Ab and ICI: (42, 5665, 67, 7173, 77, 80, 82, 98102)

EBV-directed CTL (105 - 108)

CAR-T and NK (110 - 120)

Bi-specific Ab (129 - 130)

Vaccines (103 - 104)